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A B S T R A C T
Renal Oncocytomas are rare benign renal masses. They can be easily mistaken for 
Renal Cell Cancers and patients usually undergo a radical nephrectomy. We present 
a case of a female patient who was admitted with a large mass originating from the 
right kidney. The results from the CT (stellate scar) and the angiography (spoke-wheel 
pattern) were consistent with Renal Oncocytoma, but still a radical nephrectomy was 
performed. This decision was made due to the inability of the current diagnostic pro-
cedures to safely differentiate Renal Oncocytomas from Renal Cell Cancers.
I n T R o d u C T I o n 
The first case of Renal Oncocytoma (RO) was described in 1942 by Zippel.1 ROs 
represent highly differentiated granular cell renal parenchymall tumors. They are 
characterized by an eosinophilic cytoplasm caused by an abundance of mitochondria. 
The cell of origin is the intercalated cell of the cortical portion of the collecting tubule.2 
RO is a benign neoplasm that only rarely metastasizes and has an excellent prognosis.3 
Their clinical manifestation and radiologic findings have not yet proven consistently 
reliable to safely differentiate ROs from Renal Cell Carcinomas (RCC). We present 
a case of a 74 year-old female patient who underwent radical nephrectomy for a large 
mass originating from the right kidney, which was revealed to be a RO.
C A S e  P R e S e n T A T I o n
A 74 year-old female was admitted with a 1 year history of abdominal pain, mainly 
localized in the right flank and right loin. The patient also experienced a weight loss of 
8 kg within 8 months. On examination, there was a firm, palpable abdominal mass in 
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the right flank and loin and no other remarkable physical find-
ings. Laboratory tests were normal. Tumor markers were all 
normal. CT scan of the abdomen showed a large, multilobular, 
well demarcated mass which occupied the anatomical space 
between the right liver lobe and the right kidney, displacing the 
latter anterio-inferiorly. The mass had a dense homogenous 
circumference and a hypo-dense stellate center (stellate scar) 
(Figure 1). Digital subtraction angiography revealed a large 
vascularized mass, associated with the right kidney. Early 
arterial phase showed a spoke-wheel arterial configuration 
which refers to the radial arrangement of the vessels from 
the periphery to the central portion of the tumor (Figure 2). 
In the nephrogram phase a homogenous blush and a central 
stellate lucency within the mass were noted. The left kidney 
was normal. Due to the characteristic findings from the CT 
and angiography, the preoperative diagnosis of RO was highly 
suggestive. Once the investigations were complete, the patient 
was taken to the operational theatre, where a right radical 
nephrectomy, which included the proximal 2/3 of the ureter, 
was performed (Figure 3). There was no macroscopic evidence 
of any secondary deposits to the rest of the intra-abdominal 
structures. The patient’s postoperative course was uneventful.
Gross pathologic examination revealed a 19 X 15 X 11 
cm mass originating from the right kidney. A central whitish 
stellate scar was characteristically present (Figure 4). The 
histological examination of the specimen showed a renal 
neoplasm with morphological characteristics consistent with 
RO. The specimen was positive for CK 8,18 and CD 10, and 
negative for CK 20, VIM and RCC. The patient is doing well 
3 years after the operation.
d I S C u S S I o n
ROs are usually solitary masses and account for ap-
proximately 5% of all renal tumors. ROs are multifocal in 
2.5% to 16% of cases and bilateral in 4% to 12% of cases.4 
Metachronous tumors occur in 4% of patients. Very rarely, a 
diffuse form of innumerable, small bilateral ROs can occur.5 
Genetic predisposition to developing ROs is seen in the rare 
condition of familial RO, where bilateral tumors develop, vary-
ing from milder forms of the disorder, to severe cases where 
renal function is compromised.6
There is a peak incidence in the seventh decade. Ap-
proximately 70% of these tumors are discovered as incidental 
findings by investigations performed for an unrelated problem, 
while 30% of patients may present flank pain, palpable renal 
mass and gross or microscopic hematuria.7 
The increasing use of CT scans for small renal masses has 
led to a diagnostic dilemma of accurately characterizing the 
nature of these renal lesions and their subsequent manage-
ment. On CT scanning, ROs typically show a well-defined, 
smooth, relatively homogeneous solid mass with a central area 
of hypoattenuation due to the presence of a central stellate 
scar, and rarely show any extension to the renal vein, inferior 
vena cava or the adrenals. Classically, if renal angiography on 
ROs were performed, it would show a typical spoke-wheel pat-
tern, highlighting the marked peripheral vascularity in contrast 
with the relatively hypovascular central part of the tumor. 
However, classical hypoattenuation of the central stellate scar 
on CT scan is seen in less than one-third of ROs, and although 
characteristic of ROs, it is not diagnostic. Moreover, there are 
no consistently reliable pathognomic CT scan features that can 
FIguRe 1. CT imaging. Stellate scar. FIguRe 2. Renal angiography. Spoke-Wheel pattern.
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safely differentiate ROs from RCCs.8 
Davidson and colleagues proposed the CT criteria of a 
homogenously enhancing kidney with a central, sharply defined 
stellate area of low attenuation as predictors of a RO. Using 
these criteria, they reviewed 53 cases of ROs and 63 cases of 
RCCs but only found 67% of ROs to fulfill the criteria whereas 
16% of RCCs were incorrectly predicted to be ROs. The ac-
curacy was even poorer for smaller lesions (less than 3 cm), 
with ROs being misclassified in 18% and RCCs misclassified in 
42% of cases.9 Additionally, of 11 patients with the pathologic 
diagnosis of RO in a study by Maatman , only one patient had 
a spoke–wheel pattern on conventional angiography and no 
patient had sufficient angiographic features to establish the 
preoperative diagnosis of RO.7
Even needle biopsy or frozen section are not sufficient 
to exclude RO with focal oncocytic differentiation, although 
accuracy does increase when multiple core specimens are 
obtained.10 Additionally, to date, none of the histochemical, 
IHC or cytogenetic features has been proven to be reliable 
and specific.8
Some recent advances in imaging can maybe help alleviate 
the difficulty in the differential diagnosis between RO and 
RCC. ROs are composed of cells with numerous mitochondria 
and thus retain 99mTc-MIBI in their cells resulting in a 1.44-
fold increase in 99mTc-MIBI uptake, whereas it is shown that 
RCC have been shown to actively excrete 99mTc-MIBI from 
their cells. Some studies suggest that 99mTc-MIBI SPECT/
CT could offer a preoperative advantage in the diagnosis of 
benign solid renal tumors.11
The classical approach to a solid renal mass has generally 
been a radical nephrectomy, due to the high risk of lesion 
being an RCC. Certain situations, however (patients with an 
anatomic or functional solitary kidney, patients with bilateral 
renal masses or patients with renal insufficiency) mandate 
nephron-sparing surgery. To those situations, initial results 
with radiofrequency ablation are promising alternative thera-
pies, as are minimally invasive surgical techniques including 
laparoscopic nephron-sparing surgery and laparoscopic 
cryosurgery.12,13
C o n C L u S I o n
The possibility of a RO should always be considered in 
the evaluation of a solid renal mass. The presence of a central 
stellate scar in the CT scan and a spoke–wheel arterial con-
figuration followed by a homogenous angiographic blush in 
the angiography, although not pathognomonic, should raise 
the suspicion of RO. Further advances in radiologic imaging 
are essential in order to safely differentiate ROs from RCCs, 
so that a nephron-sparing surgical technique may be employed 
for the treatment of ROs due to its benign nature.
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